8 Biotech Stocks Facing FDA Decisions In February

As January comes to a close, which biotech stocks await FDA decisions in February that could serve as catalysts? Today’s articles identifies these stocks and delves into each of them and their respective therapies for which FDA approval is being sought – therapies that, if approved, could be used to treat conditions ranging from deep partial-thickness thermal burns to small cell lung cancer. For more, CLICK HERE.